Breaking News

25 governors call for an end to the public health emergency

Not rendering correctly? View this email as a web page here.

ISO: What You Need To Know About The Deadly New Drug

By Dr. Lawrence Weinstein Wednesday, December 21, 2022 6:10 PM

It's called ISO, short for isotonitazine, a deadly synthetic opioid that is 100X to 1000X stronger than morphine and 20X more potent than fentanyl.

Read more »

MedCity Pivot Podcast: What does the CEO of Zocdoc believe the future of telehealth to be?

By Arundhati Parmar Wednesday, December 21, 2022 2:45 PM

Kharraz made a bold declaration about telehealth back in December 2020. In the final episode of 2022, we ask him about that and more.

Read more »

Why Providers Need to Stop Overlooking Burnout Among Clinical Support Staff

By Katie Adams Wednesday, December 21, 2022 1:45 PM

While levels have gone down from their pandemic peak, burnout remains high among clinical support staff, according to a new report. It found that 70% of clinical support staff experience moderate to severe burnout, with 32% categorizing their burnout as high to severe. Along with the obvious effect it has on support staff's wellbeing, burnout also negatively impacts patient care.

Read more »

RTM Reimbursement Represents a New Age for Digital Therapeutics

By Bronwyn Spira Wednesday, December 21, 2022 1:40 PM

Ultimately, it is anticipated that CMS will further expand the use of reimbursable RTM beyond respiratory and MSK care and incorporate patient-reported information as a requirement for reimbursement of certain remote services.

Read more »

Digital Equity as a Social Determinant of Health – 3 Ways to Empower Patients

By Smriti Kirubanandan Wednesday, December 21, 2022 1:30 PM

Social determinants of health reflect conditions in the environment where an individual is born, lives, […]

Read more »

Merck Sees No Future for NGM Bio's Eye Drugs and Declines Licensing Options

By Frank Vinluan Wednesday, December 21, 2022 1:22 PM

Geographic atrophy has no FDA-approved treatments, and Merck is walking away from its contender in the chase for one. The pharmaceutical giant declined to exercise its option on several NGM Biopharmaceuticals eye programs, a decision that follows a Phase 2 clinical trial failure.

Read more »

A Travel Health Record Can Improve Patient Outcomes and Alleviate Health Concerns While Traveling

By Matt Hollingsworth Wednesday, December 21, 2022 10:53 AM

While comprehensive travel health records for those using U.S. health systems are not available today, advances in technology and the legal environment are opening the necessary doors.

Read more »

   

No comments